Patent details

Basic Information

Publication number:

EP3080163

PCT Application Number:

NL2014050859

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP148283286

PCT Publication Number:

WO2015088348

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

IMMUNOGLOBULIN-LIKE MOLECULES DIRECTED AGAINST FIBRONECTIN-EDA

French Title of Invention:

MOLÉCULES DE TYPE IMMUNOGLOBULINE DIRIGÉES CONTRE LE DOMAINE EDA DE LA FIBRONECTINE

German Title of Invention:

IMMUNOGLOBULINÄHNLICHE MOLEKÜLE GEGEN FIBRONECTIN-EDA

SPC Number:

Dates

Filing date:

12/12/2014

Grant date:

12/02/2020

EP Publication Date:

19/10/2016

PCT Publication Date:

18/06/2015

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

12/02/2020

EP B1 Publication Date:

12/02/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

12/12/2020

Expiration date:

12/12/2034

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

05/02/2020

 

 

Name:

EnCare Biotech B.V.

Address:

Yalelaan 62, 3584 CM Utrecht, Netherlands (NL)

Inventor

Name:

ARSLAN, Fatih

Address:

Netherlands (NL)

Priority

1

Priority Number:

2011943

Priority Date:

12/12/2013

Priority Country:

Netherlands (NL)

2

Priority Number:

2011944

Priority Date:

12/12/2013

Priority Country:

Netherlands (NL)

Classification

IPC classification:

A61P 9/10; C07K 16/18;

Publication

European Patent Bulletin

Issue number:

202007

Publication date:

12/02/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages